Despite extraordinary advances that have been achieved in the last few decades, cancer
continues to represent a leading cause of mortality worldwide. Lethal cancer types ultimately …

Despite major advances in therapy, cancer continues to be a leading cause of mortality. In
addition, toxicities of traditional therapies pose a significant challenge to tolerability and …

Simple Summary Tumor Treating Fields (TTFields), encompassing alternating electric fields
within the intermediate frequency range, is an anticancer treatment delivered to the tumor …

Introduction As a novel treatment modality, tumor treating fields (TTFields) exert low-
intensity, medium-frequency electric fields on tumor cells. TTFields' effectiveness and safety …

Tumor treating fields (TTFields) is a noninvasive, regional antimitotic treatment modality that
has been approved for the treatment of recurrent glioblastoma by the US FDA and has a CE …

Introduction: Local control is fundamental, both for the curative as well as the palliative
treatment of cancer. Tumor treating fields (TTFields) are low intensity (1–2 V/cm) …

Background Tumor Treating Fields (TTFields) therapy is a non-invasive, loco-regional, anti-
mitotic treatment modality that targets rapidly dividing cancerous cells, utilizing low intensity …

Although major innovations in treatment are advancing, cancer persists as one of the
leading causes of mortality. With the rising incidence of cancer and as we treat them …

Traditional cancer therapy choices for clinicians are surgery, chemotherapy, radiation and
immune therapy which are used either standalone therapies or in various combinations …

Tumor‐treating fields (TTFields) are a noninvasive antimitotic cancer treatment consisting of
low‐intensity alternating electric fields delivered to the tumor or tumor bed via externally …